Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
Revista Espanola De Enfermedades Digestivas
|
November 17, 2025
Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease
Sandra García-Mateo, Samuel Jesús Martínez-Domínguez, Carla Jerusalén Gargallo-Puyuelo, et al.
Plos One
|
March 3, 2012
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial
Rosa Solà, Rosa M Valls, Gemma Godàs, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
Teresa Vilariño-García, María L Polonio-González, Antonio Pérez-Pérez, et al.
Cardiovascular Diabetology
|
February 22, 2025
Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study
Núria Amigó, Esmeralda Castelblanco, Josep Julve, et al.
International Journal of Molecular Sciences
|
February 11, 2023
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
Pere Rehues, Josefa Girona, Montse Guardiola, et al.
Journal of Clinical Lipidology
|
February 6, 2018
Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis
Luis Masana, Josefa Girona, Daiana Ibarretxe, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
July 31, 2021
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)
Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, et al.
Biomolecules
|
September 27, 2025
Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study
Marta Tajes, Maria Del Mar Ras-Jiménez, Josefa Girona, et al.
Nutrients
|
November 27, 2021
Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review
Carlos Jiménez-Cortegana, Pedro Iglesias, Josep Ribalta, et al.
JACC. Basic to Translational Science
|
November 13, 2024
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia
Carla Borràs, Marina Canyelles, Josefa Girona, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
Revista Espanola De Enfermedades Digestivas
|
November 17, 2025
Plasma protein glycosylation: a biomarker for predicting metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease
Sandra García-Mateo, Samuel Jesús Martínez-Domínguez, Carla Jerusalén Gargallo-Puyuelo, et al.
Plos One
|
March 3, 2012
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial
Rosa Solà, Rosa M Valls, Gemma Godàs, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
Teresa Vilariño-García, María L Polonio-González, Antonio Pérez-Pérez, et al.
Cardiovascular Diabetology
|
February 22, 2025
Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study
Núria Amigó, Esmeralda Castelblanco, Josep Julve, et al.
International Journal of Molecular Sciences
|
February 11, 2023
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
Pere Rehues, Josefa Girona, Montse Guardiola, et al.
Journal of Clinical Lipidology
|
February 6, 2018
Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels-The zero-LDL hypothesis
Luis Masana, Josefa Girona, Daiana Ibarretxe, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis
|
July 31, 2021
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)
Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, et al.
Biomolecules
|
September 27, 2025
Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study
Marta Tajes, Maria Del Mar Ras-Jiménez, Josefa Girona, et al.
Nutrients
|
November 27, 2021
Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review
Carlos Jiménez-Cortegana, Pedro Iglesias, Josep Ribalta, et al.
JACC. Basic to Translational Science
|
November 13, 2024
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia
Carla Borràs, Marina Canyelles, Josefa Girona, et al.
Page
of 10